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Abstract. Haptoglobin (Hp) is an acute phase protein that removes free hemoglobin (Hb) released during hemolysis. 
Hp has also been shown to be toxic for malaria parasites. a+-Thalassemia is a hemoglobinopathy that results in 
subclinical hemolytic anemia. a+-Thassemia homozygosity confers protection against severe malarial disease by an as yet 
unidentified mechanism. Hp levels were measured in a serial cross-sectional survey of children in Madang Province, 
Papua New Guinea (PNG). Hp levels were related to age, Hp genotype, Hb levels, parasitemia, splenomegaly, and 
ot+-thalassemia genotype. Surprisingly, children who were homozygous for a+-thalassemia had significantly higher levels 
of Hp than did heterozygotes, after controlling for relevant confounders. We suggest that this is the result of either 
reduced mean cell Hb associated with a+-thalassemia homozygosity or an elevated IL-6-dependent acute phase response. 
Haptoglobin (Hp) is an acute phase protein with an impor-
tant protective role in hemolytic disease. It binds irreversibly 
to hemoglobin (Hb) and reduces the oxidative and peroxida-
tive potential of free Hb.1 The Hp–Hb complex is endocy-
tosed by macrophages through the acute phase-regulated and 
signal-inducing macrophage protein CD163.2 Hp exists in 
three phenotypic forms, Hp1-1, 2-1, and 2-2, encoded by two 
co-dominant alleles, Hp1 and Hp2.3 The Hp1 type may be 
further subdivided into two subtypes, Hp1S and Hp1F, coded 
by two alleles hp1F and hp1S.4 Allele frequencies of types and 
subtypes vary according to geographical location.4 The ability 
to bind Hb is phenotype-dependent and has been found to be 
in the order 1-1 > 2-1 > 2-2, the binding capacity reflecting the 
plasma levels of the three phenotypes.5 Various factors play a 
role in determining Hp concentration (i.e., Hp phenotype, 
age, hemolysis, and the acute phase response).6 
Hemolysis is a pathologic feature of malaria infection, and 
decreased Hp levels are associated with clinical malaria.7 Hp 
levels are reduced by both chronic, low-density, asymptom-
atic parasitemia and possibly malaria-associated immune 
complex destruction of uninfected erythrocytes.8 The preva-
lence of ahaptoglobinemia (absence of measurable Hp) is 
common in malaria endemic areas and increases with increas-
ing malaria transmission.9 Available data on the protective 
effect of Hp polymorphisms from West Africa have been geo-
graphically variable.10–13 
Interestingly, Hp is directly toxic to P. falciparum in vitro at 
concentrations that may occur during an acute phase re-
sponse.14 The exact mechanism of action is not known. Hp 
does not enter the infected erythrocyte but may act indirectly, 
disrupting normal parasite protein trafficking within the host 
cell.14 An in vivo model of malaria infection in mice has 
shown that parasite burdens and peak parasite densities were 
higher in Hp knockout mice.15 Hp has other anti-microbial 
effects; Hp has been shown to make iron unavailable to bac-
teria using Hb (e.g., E. coli) and to cause agglutination of 
Streptococcus pyogenes.16,17 
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Hemolysis is also a clinical feature of a+-thalassemia, a 
non-structural inherited disorder of Hb. a+-Thalassemia is a 
result of deletions (3.7 or 4.2 kb) or inactivation by a point 
mutation of one of the duplicated a-globin genes. The het-
erozygous and homozygous a+-thalassemia genotypes are 
(-a/ota) and ( -a / -a ) , respectively.18 In general, those hetero-
zygous and homozygous for a+-thalassemia have lower levels 
of total Hb, mean cell Hb concentration, mean corpuscular 
volume, and mean cell Hb than non-thalassemics (aa/aa).1 9 
For all parameters, there is a greater difference between het-
erozygotes and homozygotes than heterozygotes and non-
thalassemics.18 Therefore, compared with non-thalassemics, 
heterozygotes do not present any clinical symptoms, whereas 
homozygotes are characterized by mild hypochromic micro-
cytic anemia.20'21 Individuals homozygous for a+-thalassemia 
have also been shown to be protected against severe P. falci-
parum malaria as well as all cause admissions to hospital with 
other infections in Papua New Guinea (PNG).22 
There have been a number of studies of Hp in malarious 
areas that have looked either at plasma levels or at Hp ge-
notype but interestingly, not Hp genotype and levels in the 
same individuals.8'23'24 More surprisingly, no one has exam-
ined the relationship between Hp levels and hemolytic disor-
ders such as a+-thalassemia in a malaria-endemic situation. 
Given that Hp has a potentially beneficial role in malaria 
infection because of its ability to abrogate damage caused by 
free Hb and the antiparasitic effect noted in vitro, we decided 
to look at the association between Hp levels, malariometric 
indices, and host genotype in a malaria-endemic population. 
MATERIALS AND METHODS 
Study site. The study was conducted in the Amele villages 
of Madang Province on the north coast of PNG where there 
is intense year-round transmission of malaria.2S The region 
has a tropical climate with high annual rainfall (2.5-5 m) and 
high relative humidity (85-90%). A wet season is normally 
recognized between October and May. Temperatures vary 
little throughout the year (23°C average minimum to 30°C 
average maximum). The principal vectors of malaria in this 
area are members of the Anopheles punctulatus Dönitz com-
plex. The mean number of infectious bites (P. falciparum and 
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P. vivax) per day in this region is estimated at 0.86.26 Health 
services consist of an aid post providing basic health care, a 
health center at Yagaum and the nearest hospital is in 
Madang town, 35 km away by road. 
Endemic malaria in the Amele is evidenced by decreasing 
parasite prevalence and splenic enlargement with age.25 The 
spleen is enlarged during malaria because of removal of para-
sitized erythrocytes and hematopoiesis.27 Rates of splenic en-
largement and parasite rates decline substantially by the age 
of 15 years, indicating acquired immunity.25 Young children 
less than 4 years of age have more frequent clinical episodes 
of malaria associated with high parasite densities.28 Semi-
immune children more than 4 years of age from Amele har-
bor chronic, asymptomatic malaria infections of P. falci-
parum, P. vivax, P. malariae, and P. ovale, with occasional 
episodes of clinical malaria associated with splenomegaly and 
parasitemia above the fever threshold of 1,000 parasites/ 
(xL of blood.28,29 
ot+-Thalassemia reaches very high frequencies in the Amele 
region.30 The a3.7 deletion can be of three different subtypes 
(I, II, III). a3.7 I I I is only found in Melanesia and is the dom-
inant form, except on the north coast of PNG, where a4.2 
predominates.31 Polymorphisms such as Southeast Asian 
ovalocytosis (SAO) and glucose 6-phosphate dehydrogenase 
(G6PD) deficiency are also present in this area.32,33 The Hp1 
allele is present at a frequency of 69% in Melanesians, but the 
Hp1F form has not been reported.34,35 
Study design. A serial cross-sectional survey was conducted 
in asymptomatic children living in villages of the Amele re-
gion, Madang Province, PNG. The study took place from 
November to December of 1999 and 2000. The children were 
invited to attend the first cross-sectional study at school or by 
house visit after consultation with parents at a village meet-
ing. The aim was to recruit 1,000 individuals 1-17 years of age 
in the first year and encourage them to return the following 
year. 
One thousand fifteen individuals were recruited into the 
survey in 1999, and 623 individuals returned for the second 
data collection in 2000. A further 76 individuals were ex-
cluded because of insufficient or missing data. Loss to follow-
up from the study took place predominantly in children 1-4 
years of age who were surveyed at home. Disruption to par-
ents’ agricultural practice accounted for lack of compliance at 
the second survey. Those who had insufficient data were also 
in this age group because smaller children only had a finger 
prick of blood taken. The most reliable places sampled were 
schools, where children regularly attended lessons from 7 
years of age. 
Data collection. Axillary temperature was recorded for 
each child, and fever was defined as a temperature > 37.5°C. 
Examination for splenomegaly was conducted by detecting 
the number of finger widths of spleen detectable below the rib 
line (the Hacketts grading system). Venous blood was drawn 
using Vacutainer tubes (Becton Dickinson, Oxford, UK) con-
taining EDTA as an anti-coagulant. A blood smear was im-
mediately made and later stained with Giemsa. Levels of Hb 
were also immediately determined using a Hb photometer 
(HemoCue AB, Angelholm, Sweden). Malaria-related ane-
mia was defined as Hb < 8 g/dL.36 Whole blood was blotted 
onto Isocode Stix filter paper (Schleicher & Schuell, Dassel, 
Germany) following the manufacturer’s instructions for fur-
ther use in human genetic analyses. The remaining blood was 
centrifuged and separated into plasma (stored at -80°C), 
buffy coat and erythrocyte pellet, both stored in guanidine 
hydrochloride (G-HCl) at 4°C. 
Parasitology. Plasmodium species and counts (number of 
parasites per 200 leukocytes) were analyzed by microscopy 
and recorded. A parasite negative slide was one on which 
2,000 leukocytes were observed and no parasites seen. Dupli-
cate readings were made for 20% of smears. Greater than 
75% concordance in results was observed, and therefore ini-
tial results were accepted. This is the standard test of repro-
ducibility carried on blood surveys by the PNG Institute of 
Medical Research. Generally, parasite counts are made per 
200 leukocytes and converted assuming a standard leukocyte 
count of 8.0 x 103/(xL of blood. The most accurate counts of 
parasite density are obtained by counting parasites per leu-
kocyte and converting this to parasites per microliter of blood 
using a mechanized Coulter leukocyte count of the same 
blood sample. Previous analysis has compared general para-
site counts to parasite counts form Coulter counter leukocyte 
counts in asymptomatic children from Madang (M. Bruce, 
unpublished observations). Variation in the Coulter count in 
all age groups resulted in over-estimates of up to 2.0 times and 
under-estimates of up to 0.4 times the actual parasite density 
when a standard value of 8.0 x 103 leukocytes/jxL of blood is 
used. The leukocyte count was not available for each blood 
sample, but the following age-stratified leukocyte counts were 
used to calculate parasites per microliter of blood: < 4 years, 
8.6 x 103 leukocytes/jxL; 5-9 years, 7.8 x 103 leukocytes/jxL; 
> 10 years, 7.7 x 103 leukocytes/jxL (M. Bruce, unpublished 
data). 
Laboratory methods. DNA polymorphism analysis. DNA 
samples were purified with Glassmilk (Qbiogene Inc., UK) 
from leukocytes stored in Guanadine-HCl, as recommended 
by the manufacturer. Hp alleles were determined by polymer-
ase chain reaction (PCR) using 0.025 U/jxL HotStar Taq 
DNA polymerase (Qiagen) with supplied buffer, oligonucle-
otide primers (200 nmol/L each), dNTPs (200 (xmol/L each) in 
two separate reactions as follows: Hp1, forward primer (5'-
GGGGACAGCTTTTTGCAGTGG-3'), reverse primer (5'-
GCCGGATTCTTGGGCTTCCC-3') subjected to 94°C for 
15 minutes, 35 cycles of 15 seconds at 94°C, 30 seconds at 
60°C, and 2 minutes at 72°C; Hp2, forward primer (5'-GTT-
GGAGATAAACTTCCTGAATGTGAAGC-3 ' ) , reverse 
primer (5'-CCACATAGCCATGTGCAATCTCG-3') sub-
jected to 94°C for 15 minutes, 7 cycles of 15 seconds at 94°C, 
30 seconds at 60°C, decreasing 0.5°C at each cycle, and 2 
minutes at 72°C; 35 cycles of 15 seconds at 94°C, 30 seconds 
at 57°C, and 2 minutes at 72°C Each individual had either a 
band corresponding to the Hp1 allele, a band corresponding 
to the Hp2 allele, or two bands if both alleles were present. 
ot+-Thalassemia genotypes were determined in a single-tube 
multiplex PCR with some modifications.37 In short, approxi-
mately 1 mm2 of Isocode Stix paper blotted with blood 
samples was washed with H2O and directly PCR-amplified 
with the reaction mixture: 0.05 U/jxL AmpliTaq Gold DNA 
polymerase (Applied Biosystems) with its supplied buffer, 1.5 
mmol/L MgCl2, 200 (xmol/L each dNTP, 1 mmol/L betaine 
(Sigma), 5% dimethyl-sulfoxide (Sigma), and oligonucleo-
tides a2/3.7-F (400 nmol/L), 3.7/20.5-R (400 nmol/L), a2-R 
(200 nmol/L), 4.2-F (400 nmol/L), and 4.2-R (400 nmol/L).37 
The reaction was subjected to 94°C for 15 minutes; 35 cycles 
of 15 seconds at 94°C, 30 seconds at 60°C, and 3 minutes at 
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72°C. SAO (band 3 deletion) was genotyped by PCR using 
human DNA from Isocode Stix as described above.38 G6PD 
deficiency was evaluated qualitatively (Sigma Diagnostics vi-
sual colorimetric assay), and ABO blood groups were deter-
mined using anti-A and anti-B antibodies from a kit 
(BIOSCOT, Edinburgh, UK). The information available for 
each polymorphism varied because of the lack of enough 
blood, loss of the sample, or unsuccessful typing. 
Hp assay. Plasma Hp levels were determined by enzyme-
linked immunosorbent assay (ELISA) as published previ-
ously.39 This method was comparable with results from radial 
immunodiffusion assays (Dade Baring) using plasma from 
white controls (R2 = 0.9022; H. Imrie, unpublished data). 
The median (range) of Hp levels using the ELISA in these 
white controls was 1.653 mg/mL (range, 0.05-3.13 mg/mL). 
Statistical analysis. Because of the repeated measures study 
design, appropriate statistical tests were chosen to analyze 
paired data. The frequency of sex by age in 1999 was assessed 
by a x2 test. Differences in categorical variables between 1999 
and 2000 were assessed using McNemar test. Differences in 
Plasmodium density for positive slides between 1999 and 2000 
were assessed using a Wilcoxon signed rank test, and those in 
Hb levels using a paired t test. In each case, the analysis only 
included subjects with data available for both years. Within 
each year, the frequencies of the categorical malariometric 
indices by age were assessed by x2 tests, that of Plasmodium 
density by a Kruskal-Wallis test, and that of Hb and tempera-
ture by analysis of variance. Associations between host poly-
morphisms and malariometric indices were examined using x2 
tests, ordinal regression, Kruskal-Wallis tests, and analysis of 
variance. Finally the associations between Plasmodium den-
sity, Hb, and genotypes and between Hp levels and the other 
variables were examined using linear mixed models (equiva-
lent to multiple regressions but adjusting for correlation be-
tween the values for the same subject by including a random 
effect for each subject). 
Data considerations. Because the Hp levels showed con-
siderable heteroscedasticity (non-constancy of the variance), 
the levels were transformed before analysis, using the trans-
formation log(Hp + 0.05). This was chosen by examining pro-
file likelihoods.40 The Plasmodium densities were trans-
formed by log(Plasmodium spp. + 1) in the mixed model 
analyses to reduce the skewness but leaving the zero values 
unchanged. Additional exclusion criteria for the analysis 
were those with clinical malaria defined as parasites > 1,000/ 
(xL of blood and temperature > 37.5°C (N = 11 in 1999, N = 
23 in 2000).28 
Details of Hp regression analysis. The linear mixed models 
were developed using R 1.8.1,41 and the stepwise search was 
performed on a data set that omitted all subjects for whom 
any data were missing. The stepwise procedure, with Akaike’s 
information criterion (AIC) as the criterion of goodness of fit, 
was commenced at a model including Hp genotype, a+-
thalassemia genotype, presence of splenomegaly, Hb level 
(continuous variable), and age (continuous variable). The full 
model examined the effect of P. falciparum (four categories 
or logarithm of density), P. vivax (four categories or quadratic 
effect of logarithm of density), P. malariae (two categories or 
logarithm of the density), and P. falciparum gametocytes (two 
categories or logarithm of density), sex, ABO blood groups, 
SAO and G6PD genotypes, temperature together with a qua-
dratic term for Hb, and interactions between variables. The 
final model was refitted to a data set excluding only those 
subjects with missing data for the variables that remained in 
the model, and variables with P > 0.05 were removed. P val-
ues reported are adjusted for multiple comparisons using 
Bonferroni. 
SPSS for Windows (version 11.5) was used for the analysis 
with the exception of the Hp linear mixed model, which was 
developed in R1.8.1.41 
The project received ethical approval from the PNG Medi-
cal Research Advisory Committee and Institutional Review 
Board of the New York University School of Medicine. 
RESULTS 
Full cohort descriptives. Study subjects. A serial cross-
sectional study took place in the Amele region, Madang, 
PNG, in November to December 1999 and 2000. After exclu-
sions, the study consisted of 547 individuals (51% boys) 1-17 
years of age in 1999. Table 1 shows age-specific and overall 
frequencies of malariometric indices in both cross-sectional 
studies in 1999 and 2000. Overall, there was no statistical 
difference (P > 0.05) between malariometric data in the 
2 collection years with the exception of P. vivax prevalence 
(P = 0.04). 
Frequencies of host polymorphisms for the study popula-
tion are detailed in Table 2. There were no significant asso-
ciations between any of the host polymorphisms (P > 0.1). 
There was an association between G6PD and sex (P = 0.009). 
TABLE 1 
Age-specific and overall prevalence of malriometric indices 
Survey 
1999 
2000 
Age class (years) 
1-4 
5-9 
10-17 
Total 
1-4 
5-9 
10-17 
Total 
n 
94 
188 
254 
536 
70 
153 
301 
524 
P. 
Prevalence 
35.1 
39.6 
37.4 
37.8 
P = 0.76 
18.2 
33.8 
43.2 
37.2 
P < 0.001 
falciparum 
Density 
3.08 (0.86) 
2.78 (0.82) 
2.72 (0.71) 
2.8 (0.78) 
P = 0.07 
2.86 (0.84) 
2.87 (0.85) 
2.66 (0.74) 
2.73 (0.78) 
P = 0.21 
Prevalence 
26.6 
32.1 
26.8 
28.6 
P = 0.43 
47.3 
33.1 
12.6 
23.1 
P < 0.001 
P. vivax 
Density 
2.62 (0.63) 
2.46 (0.62) 
2.19 (0.54) 
2.36 (0.61) 
P = 0.003 
2.88 (0.79) 
2.34 (0.7) 
1.95 (0.44) 
2.36 (0.74) 
P < 0.001 
Splenomegaly 
Prevalence 
23.7 
33.5 
16.5 
23.7 
P < 0.001 
30.4 
31.4 
13.4 
20.9 
P < 0.001 
Hemoglobin (mg/dL) 
10.07 (1.75) 
11.03 (1.78) 
11.43 (1.51) 
11.02 (1.73) 
P < 0.001 
10.01 (1.48) 
10.3 (1.43) 
11.14 (1.27) 
10.75 (1.44) 
P < 0.001 
Continuous variables are shown as mean value (SD). Prevalence is defined as the percentage of subjects with malarial parasites/splenomegaly. Density is log10 value/jxL of positive slides. P. 
falciparum gametocytes were found in 9.5% and 7.8% of samples in 1999 and 2000, respectively. 
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TABLE 2 
Frequency of host polymorphisms 
Frequency 
Host polymorphism 
a+-Thalassemia genotype 
aa /aa 
-a/aa 
-a/-a 
Missing data 
Haptoglobin genotype 
1-1 
2-1 
2-2 
Missing data 
ABO blood group 
A 
AB 
B 
O 
Missing data 
SAO genotype 
SAO 
Wild type 
Missing data 
G6PD phenotype 
Not normal 
Normal 
Missing data 
n 
39 
201 
306 
1 
201 
240 
104 
2 
175 
55 
136 
178 
3 
49 
497 
1 
55 
469 
23 
(%) 
(7.1) 
(36.7) 
(55.9) 
(0.2) 
(36.7) 
(43.9) 
(19.0) 
(0.4) 
(32.0) 
(10.1) 
(24.9) 
(32.5) 
(0.5) 
(9.0) 
(90.8) 
(0.2) 
(10.1) 
(85.7) 
(4.2) 
Missing data represents unsuccessful genotyping/phenotyping. SAO; Southeast Asian 
ovalocytosis; G6PD; glucose-6-phospate dehydrogenase deficiency. 
Boys had a higher prevalence of G6PD deficiency (14%) 
compared with girls (7%). 
Host polymorphisms and malariometric indices. Host 
erythrocyte polymorphisms could influence hemolysis and 
thereby Hp levels. This could occur either directly, where the 
polymorphism is associated with hemolytic anemia, or indi-
rectly by influencing parasitemia. There were few associations 
between host polymorphisms and parasite prevalence in the 2 
study years. In 1999, both blood group B and Hp genotype 
were associated with parasite prevalence (P = 0.009 and P = 
0.05, respectively). Blood group B had significantly lower 
prevalence of Plasmodium (54.9%) compared with A 
(77.8%), AB (77.8%), and O (67.12%), whereas Hp 2-2 had 
higher prevalences (75.7%) compared with 1-1 (63.8%) and 
2-1 (62.4%). In 2000, non-thalassemics had a lower preva-
lence of Plasmodium (37.1%) compared with homozygotes 
and heterozygotes (61.9% and 62.4%, respectively, P = 0.01). 
There was no association between host polymorphisms and 
mean parasite density (P > 0.05). 
Mean Hb levels were significantly associated with a+-
thalassemia after controlling for age and parasite density. a+-
Thalassemia homozygotes had lower mean Hb levels (10.78 
g/dL; 95% CI, 10.64, 10.91) compared with heterozygotes 
(11.04 g/dL; 95% CI, 10.88, 11.21; P = 0.04) and non-
thalassemics (11.16 g/dL; 95% CI, 10.78, 11.54; P = 1.0). 
Ordinal regression was used to examine associations between 
host polymorphisms and splenomegaly in both years, 1 year, 
or neither years. Splenomegaly, was associated with both sex 
(P = 0.026) and SAO (P = 0.002) after controlling for age. 
Girls had a higher prevalence of normal spleens in both stud-
ies (71.0%) compared with boys (62.0%). Individuals with 
SAO had a higher prevalence of splenomegaly in both 
(19.1%) or one (36.2%) of the studies compared with normals 
(10.2% and 21.1%, respectively). There was no significant 
association between host polymorphisms and mean tempera-
ture or fever (P > 0.05). 
Haptoglobin. After exclusions, 547 children contributed 
1,060 Hp measurements for the analysis (536 in 1999 and 524 
in 2000). Median Hp levels in 1999 were 0.275 (range, 0-3.35) 
and 0.25 (range, 0-2.85) mg/mL in 2000. There was no signifi-
cant difference in Hp levels between the 2 years (P = 0.34). 
Ahaptoglobinemia (absence of detectable Hp) was present in 
16 individuals in 1999 and 7 individuals in 2000. The preva-
lence of hypohaptoglobinemia (Hp < 0.18 mg/mL) was found 
in 39.6% and 38.2% of children in 1999 and 2000, respec-
tively. 
Multivariate analysis. A linear mixed model was used to 
examine the effect of a large number of variables on Hp 
levels. The resulting fitted mixed model predicts the median 
Hp level and 95% CIs for the population controlling for rel-
evant variables. The final model chosen included Hp geno-
type, a+-thalassemia, splenomegaly, age, Hb (quadratic ef-
fect), P. falciparum, P. vivax (quadratic effect), and gameto-
cyte density. No evidence of interaction between these 
variables was found. 
The overall Hp level in this population after controlling for 
relevant variables was 0.264 mg/mL (95% CI, 0.216, 0.321). 
The model predicts a difference in median Hp between the 
different Hp genotypes (overall P = 0.002; Figure 1). The 
model also showed differences in median Hp according to 
a+-thalassemic genotype (overall P = 0.011). Homozygotes 
had significantly higher Hp than heterozygotes (Figure 2). 
Non-thalassemic individuals had a median Hp level of 0.256 
mg/ml (95% CI, 0.186, 0.346), but this did not differ signifi-
cantly from either homozygotes or heterozygotes (P > 0.78). 
Hp levels decreased with age (P < 0.001), decreasing Hb (P < 
0.001), and increasing parasite densities (P < 0.005; Figure 3). 
Individuals with splenomegaly had median Hp levels of 0.219 
mg/mL (95% CI, 0.173, 0.275), which were lower compared 
with those with normal spleens (0.261 mg/mL; 95% CI, 0.261, 
0.382; P < 0.001). 
DISCUSSION 
To determine the influence of malariometric indices and 
host polymorphisms on Hp concentrations, a serial cross-
FIGURE 1. Median Hp levels in P N G children according to Hp 
genotype. Error bars correspond to 95% CIs. 
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FIGURE 2. Median Hp levels in P N G children according to a+-
thalassemia genotype. Error bars correspond to 95% CIs. 
sectional study was undertaken in Madang Province, PNG. 
Hematological parameters would be expected to vary in an 
individual exposed to malaria infection. The serial study de-
sign ensured that any real difference in Hp levels, with respect 
to host genetics, would be seen in both years thereby reducing 
the possibility of these results occurring by chance. Overall, 
there was no statistical difference between prevalences of ma-
lariometric indices between the 2 years, and children showed 
typical age-related patterns of malaria infection for this 
area.25 
The frequency of a+-thalassemia and other host polymor-
phisms are very consistent with previous studies in the Amele 
region.22 ,30 ,32 ,42 ,43 Lower prevalences of Plasmodium 
were found in individuals with blood group B and Hp 2-2 in 
1999 and non-thalassemics in 2000. These results were not 
consistent in both years and may therefore have occurred by 
chance. There was no difference between parasite density and 
FIGURE 3. Predicted Hp levels according to Plasmodium spp. 
density. Hp levels decrease with increasing parasite density (P < 
0.005). 
host genotype in this study as assessed by mixed linear mod-
els. Furthermore, data from the same children showed that 
rates of seroconversion to P. falciparum variant surface anti-
gens are the same, regardless of host genotype (P.M., unpub-
lished data). Interestingly, splenomegaly prevalence was sig-
nificantly elevated in ovalocytic subjects. This is not consis-
tent with other studies, but the enlargement of the spleen in 
these individuals may be explained by the selective removal 
of ovalocytic erythrocytes by the spleen.32,43 a+-Thalassemia 
homozygotes had lower mean Hb levels compared with het-
erozygotes. This is a common consequence of this genotype, 
which experiences reduced erythrocyte indices and, in par-
ticular, hemolytic anemia.20,21 G6PD deficiency was more 
prevalent in boys in this study. The G6PD gene is on the X 
chromosome, and sex differences have been previously 
noted.44 
Multivariate analysis showed that levels of Hp were related 
to Hp genotype, age, total Hb, parasite density, splenomega-
ly, and a+-thalassemia genotype. The relationship between 
Hp levels and Hp phenotype has been noted by others.6 
Hp2-1 and 2-2 are polymeric, whereas Hp1-1 is a tetramer.3 
The binding of one Hb molecule to one molecule of a poly-
meric form of Hp and its subsequent clearance would result in 
a greater relative reduction in the total pool of Hp available 
compared with the clearance of one Hp1-1 tetramer. Further-
more, clearance of 2-2 complexes of Hb-Hp exhibit higher 
functional affinity for CD163 than do complexes of Hp1-1-
Hb.2 
Hp levels were found to decrease with age from 1 to 17 
years in this cohort. A study in a malaria endemic area of The 
Gambia also found levels decrease with age to 10 years.23 Hp 
concentration was positively correlated with Hb levels and 
inversely related to parasite density of all Plasmodium spp., 
presumably because of the rapid clearance of the Hp-Hb 
complex during hemolysis. Levels were highest in children 
infected with P. vivax, because P. vivax densities were lower 
in these children. High parasite densities and possibly mass 
hemolysis of infected erythrocytes may induce gametocyto-
genesis.4 This may explain why Hp levels were lowest in 
children with P. falciparum gametocytes. Hp levels were also 
reduced in the presence of splenomegaly, which occurs in 
children experiencing high-density malaria infection in the 
Amele population.2 28 
Our data also showed that levels of Hp varied with a+-
thalassemia genotype. There was no significant difference be-
tween non-thalassemics and either heterozygotes or homozy-
gotes. This was probably because of the low frequency of 
non-thalassemics in the study population resulting in a high 
variance in the estimates of their median Hp levels. Median 
levels in non-thalassemics (0.264 mg/mL; 95% CI, 0.216, 
0.321) were lower than that found in whites (1.653 mg/mL; 
range, 0.05-3.13 mg/mL; H. Imrie, unpublished observations) 
of the same age; this is because of hemolysis experienced 
during chronic malaria infections that children in this area 
harbor.29,46 The levels in this study fall within the range of 
that previously reported in other areas of PNG.47,48 After 
stratification for Hp phenotype, one study showed levels com-
parable with ours in the lowlands of PNG but higher levels in 
the highlands where malaria is absent or epidemic.47 
Hp levels were significantly higher in individuals who were 
homozygous compared with heterozygous for a+-thalassemia. 
This finding was unexpected; in a+-thalassemia homozygos-
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ity, the primary pathophysiology is that of increased periph-
eral hemolysis marked in this study by the decreased Hb in 
those with this genotype. 1 8 , 2 0 Thus , reduced levels of Hp 
would be predicted in homozygotes compared with heterozy-
gotes because of increased clearance of H b . This result could 
be explained by differences in 1) parasitemia, 2) mean cell 
hemoglobin (MCH) , or 3) increased product ion of Hp by 
homozygotes compared with heterozygotes. 
A possible explanation for the higher levels of Hp in a+-
thalassemic homozygotes is that they experience fewer Plas-
modium infections than heterozygotes. This would reduce he-
molysis and increase Hp levels. There were no significant 
differences in either Plasmodium prevalence or density be-
tween the a+- thalassemia genotypes. This is consistent with 
other studies in the area.2 2 
Alternatively, hematological parameters could explain the 
result. Homozygotes have lower M C H . 1 8 Therefore , after 
H p - H b clearance, more Hp would be present in the plasma 
per erythrocyte lysed. However , the relative contributions of 
M C H and hemolysis, associated with individuals with a + -
thalassemia homozygosity, and Hp levels is unknown, particu-
larly in the presence of malaria. 
T h e h e m a t o l o g i c a l a b n o r m a l i t y a s s o c i a t e d wi th a + -
thalassemia homozygosity could also cause elevated produc-
t ion of H p . T h e hemoly t i c a n e m i a associa ted wi th a + -
thalassemia may cause an elevated product ion of Hp by hepa-
tocytes through interleukin (IL)-6 because of the effects of 
free Hb . 4 9 , 5 0 Also, Hb is rapidly transformed into methemo-
globin, within the circulation, which acts directly on endothe-
lial cells causing t hem to secrete IL-6. 5 1 IL-6 stimulates the 
release of Hp by hepatocytes. In addition, while acute, severe 
hemolysis (e.g., that associated with clinical malaria) will al-
ways result in a reduction of Hp because of clearance; the 
outcome of chronic, low-level hemolysis (e.g., that associated 
with a+- thalassemia and/or subclinical malaria) is harder to 
predict, being a balance between the loss of Hp through clear-
ance and increased product ion caused by IL-6. 
In conclusion, we showed that a+ - thalassemia homozygotes 
have increased levels of Hp during asymptomatic malaria in-
fection. This may be because of differences in M C H - or IL-
6-dependent responses. The potent ial role of acute phase 
proteins in the role of a + - tha lassemia-media ted protect ion 
has yet to be elucidated. Whe the r acute phase proteins act as 
a possible marker , contr ibutor to, or effector for this protec-
tion warrants further investigation. Addi t ional studies are 
also required to explore differences in Hp levels in thalas-
semics outside of P N G and malaria-endemic areas. 
Received August 20, 2005. Accepted for publication February 2, 
2006. 
Acknowledgments: For field work, we are indebted to the staff of the 
Papua New Guinea Institute of Medical Research and to the Amele 
community for agreeing to take part in this study. Ruth Ripley gave 
advice on statistical analysis. Clare Watkinson and Sam Mason gave 
technical support, and the authors thank Michael Alpers and Sir 
David Weatherall for long-term contribution to a-thalassemia re-
search in Melanesia. 
Financial support: This work was funded by the Wellcome Trust and 
the European Community (E.C.Grant IC18-CT98-0359). 
Authors’ addresses: Heather Imrie and Jennifer C.C. Hume, Peter 
Medawar Building for Pathogen Research, Department of Zoology, 
South Parks Road, Oxford University, Oxford, OX1 3SY, United 
Kingdom, E-mails: heather.imrie@medawar.ox.ac.uk and Jennifer 
.hume@medawar.ox.ac.uk. Freya J.I. Fowkes and K.P. Day, Depart-
ment of Medical Parasitology, New York University School of Medi-
cine, 341 East 25th Street, New York, NY 10010, Telephone: 212-
263-6800, Fax: 212-263-8116, E-mails: frey.fowkes@med.nyu.edu and 
Karen.day@med.nyu.edu. Pascal Michon and Livingstone Tavul, 
Papua New Guinea Institute of Medical Research, P.O. Box 378, 
Madang 511, Papua New Guinea, Telephone: 675-852-2909, Fax: 675-
852-3289, E-mails: pmichon@datec.net .pg and livingstone 
.tavul@pngimr.org.pg. Karen P. Piper, CRUK Institute for Cancer 
Studies, University of Birmingham, Vincent Drive, Edgbaston, Bir-
mingham, B15 2TT, E-mail: k.p.piper@bham.ac.uk. John C. Reeder, 
Papua New Guinea Institute of Medical Research, P.O. Box 60, 
Goroka, EHP 441, Papua New Guinea, E-mail: john.reeder@ 
pngimr.org.pg. 
R E F E R E N C E S 
1. Lim SK, Ferraro B, Moore K, Halliwell B, 2001. Role of hapto-
globin in free hemoglobin metabolism. Redox Report. Com-
mun Free Rad Res 6: 219-227. 
2. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman 
HJ, Law SK, Moestrup SK, 2001. Identification of the haemo-
globin scavenger receptor. Nature 409: 198-201. 
3. Dobryszycka W, 1997. Biological functions of haptoglobin—new 
pieces to an old puzzle. Eur J Clin Chem Clin Biochem 35: 
647-654. 
4. Delanghe JR, Langlois MR, 2002. Haptoglobin polymorphism 
and body iron stores. Clin Chem Lab Med 40: 212-216. 
5. Okazaki T, Nagai T, 1997. Difference in hemoglobin-binding 
ability of polymers among haptoglobin phenotypes. Clin Chem 
43: 2012-2013. 
6. Langlois M, Delanghe J, DeBuyzere M, 1996. Relation between 
serum IgA concentration and haptoglobin type. Clin Chem 42: 
1722-1723. 
7. McGuire W, D’Alessandro U, Olaleye BO, Thomson MC, 
Langerock P, Greenwood BM, Kwiatkowski D, 1996. C-
reactive protein and haptoglobin in the evaluation of a com-
munity-based malaria control programme. Trans R Soc Trop 
Med Hyg 90: 10-14. 
8. Trape JF, Fribourgblanc A, Bosseno MF, Lallemant M, Engler R, 
Mouchet J, 1985. Malaria, cause of ahaptoglobinemia in Afri-
cans. Trans R Soc Trop Med Hyg 79: 430–434. 
9. Trape JF, Fribourgblanc A, 1988. Ahaptoglobinemia in African 
Populations and Its Relation to Malaria Endemicity. Am J 
Epidemiol 127: 1282-1288. 
10. Elagib AA, Kider AO, Akerstrom B, Elbashir MI, 1998. Asso-
ciation of the haptoglobin phenotype (1-1) with falciparum 
malaria in Sudan. Trans R Soc Trop Med Hyg 92: 309-311. 
11. Quaye IKE, Ekuban FA, Goka BQ, Adabayeri V, Kurtzhals 
JAL, Gyan B, Ankrah NA, Hviid L, Akanmori BD, 2000. 
Haptoglobin 1-1 is associated with susceptibility to severe Plas-
modium falciparum malaria. Trans R Soc Trop Med Hyg 94: 
216-219. 
12. Bienzle U, Eggelte TA, Adjei LA, Dietz E, Ehrhardt S, Cramer 
JP, Otchwemah RN, Mockenhaupt FP, 2005. Short Commu-
nication: Limited influence of haptoglobin genotypes on severe 
malaria in Ghanaian children. Trop Med Int Health 10: 668-
671. 
13. Aucan C, Walley AJ, Greenwood BM, Hill AV, 2002. Haptoglo-
bin genotypes are not associated with resistance to severe ma-
laria in The Gambia. Trans R Soc Trop Med Hyg 96: 327-328. 
14. Imrie H, Carter M, Hadjuk S, Day KP, 2004. Killing of Plasmo-
dium falciparum by human serum haptoglobin. Mol Biochem 
Parasitol 133: 93-98. 
15. Hunt NH, Driussi C, Sai-Kiang L, 2001. Haptoglobin and ma-
laria. Redox Rep 6: 389-392. 
16. Eaton JW, Brandt P, Mahoney JR, Lee JT Jr, 1982. Haptoglobin: 
a natural bacteriostat. Science 215: 691-693. 
17. Delanghe J, Langlois M, Jin OY, Claeys G, DeBuyzere M, Wuyts 
B, 1998. Effect of haptoglobin phenotypes on growth of Strep-
tococcus pyogenes. Clin Chem Lab Med 36: 691-696. 
18. Weatherall DJ, Clegg JB, 2001. The Thalassaemia Syndromes. 
Oxford, UK: Blackwell Science. 
19. Higgs D, Bowden DK, 2001. Clinical and laboratory features of 
HP AND THALASSEMIA IN PNG 971 
the alpha-thalassemia syndromes. Steinburg M, Forget B, 
Higgs D, Nagel RL, eds. Disorders of Hemoglobin: Genetics, 
Pathophysiology, and Clinical Management. Cambridge, UK: 
Cambridge University Press, 431–469. 
20. Poyart C, Wajcman H, 1996. Hemolytic anemias due to hemo-
globinopathies. Mol Aspects Med 17: 129-142. 
21. Weatherall DJ, 1998. Pathophysiology of thalassaemia. Baillieres 
Clin Haematol 11: 127-146. 
22. Allen SJ, O’Donnell A, Alexander ND, Alpers MP, Peto TEA, 
Clegg JB, Weatherall DJ, 1997. alpha+-Thalassemia protects 
children against disease caused by other infections as well as 
malaria. Proc Natl Acad Sci USA 94: 14736-14741. 
23. Sisay F, Byass P, Snow RW, Greenwood BM, Perrin LH, Yerly S, 
1992. Measurement of serum haptoglobin as an indicator of the 
efficacy of malaria intervention trials. Trans R Soc Trop Med 
Hyg 86: 14-16. 
24. Hill AVS, Whitehouse DB, Bowden DK, Hopkinson DA, 
Draper CC, Peto TEA, Clegg JB, Weatherall DJ, 1987. Ahap-
toglobinemia in melanesia—DNA and malarial antibody stud-
ies. Trans R Soc Trop Med Hyg 81: 573-577. 
25. Cattani JA, Tulloch JL, Vrbova H, Jolley D, Gibson FD, Moir JS, 
Heywood PF, Alpers MP, Stevenson A, Clancy R, 1986. The 
epidemiology of malaria in a population surrounding Madang, 
Papua New Guinea. Am J Trop Med Hyg 35: 3-15. 
26. Burkot TR, Graves PM, Cattan JA, Wirtz RA, Gibson FD, 1987. 
The efficiency of sporozoite transmission in the human malar-
ias, Plasmodium falciparum and P. vivax. Bull World Health 
Organ 65: 375-380. 
27. Engwerda CR, Beattie L, Amante FH, 2005. The importance of 
the spleen in malaria. Trends Parasitol 21: 75-80. 
28. Cox MJ, Kum DE, Tavul L, Narara A, Raiko A, Baisor M, Alp-
ers MP, Medley GF, Day KP, 1994. Dynamics of malaria para-
sitaemia associated with febrile illness in children from a rural 
area of Madang, Papua New Guinea. Trans R Soc Trop Med 
Hyg 88: 191-197. 
29. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell 
JW, Walliker D, Day KP, 2000. Cross-species interactions be-
tween malaria parasites in humans. Science 287: 845-848. 
30. Flint J, Hill AV, Bowden DK, Oppenheimer SJ, Sill PR, Ser-
jeantson SW, Bana-Koiri J, Bhatia K, Alpers MP, Boyce AJ, 
Weatherall DJ, Clegg JB, 1986. High frequencies of alpha-
thalassaemia are the result of natural selection by malaria. 
Nature 321: 744–750. 
31. Flint J, Harding RM, Boyce AJ, Clegg JB, 1993. The population 
genetics of the haemoglobinopathies. Baillieres Clin Haematol 
6: 215-262. 
32. O’Donnell A, Allen SJ, Mgone CS, Martinson JJ, Clegg JB, 
Weatherall DJ, 1998. Red cell morphology and malaria anae-
mia in children with Southeast-Asian ovalocytosis band 3 in 
Papua New Guinea. Br J Haematol 101: 407-412. 
33. Brabin L, Brabin BJ, 1990. Malaria and glucose 6-phosphate de-
hydrogenase deficiency in populations with high and low 
spleen rates in Madang, Papua New Guinea. Hum Hered 40: 
15-21. 
34. Hill AVS, Bowden DK, Flint J, Whitehouse DB, Hopkinson DA, 
Oppenheimer SJ, Serjeantson SW, Clegg JB, 1986. A popula-
tion genetic survey of the haptoglobin polymorphism in 
melanesians by DNA analysis. Am J Hum Genet 38: 382-389. 
35. Mastana SS, Bernal JE, Onyemelukwe GC, Papiha SS, 1994. 
Haptoglobin subtypes among 4 different populations. Hum 
Hered 44: 10-13. 
36. Harvey PW, Heywood PF, Nesheim MC, Galme K, Zegans M, 
Habicht JP, Stephenson LS, Radimer KL, Brabin B, Forsyth 
K, Alpers M, 1989. The effect of iron therapy on malarial 
infection in Papua New Guinean schoolchildren. Am J Trop 
Med Hyg 40: 12–18. 
37. Chong SS, Boehm CD, Higgs DR, Cutting GR, 2000. Single-tube 
multiplex-PCR screen for common deletional determinants of 
alpha-thalassemia. Blood 95: 360–362. 
38. Jarolim P, Palek J, Amato D, Hassan K, Sapak P, Nurse GT, 
Rubin HL, Zhai S, Sahr KE, Liu SC, 1991. Deletion in eryth-
rocyte band 3 gene in malaria-resistant Southeast Asian ovalo-
cytosis. Proc Natl Acad Sci U S A 88: 11022–11026. 
39. Fowkes FJ, Imrie H, Migot-Nabias F, Michon P, Justice A, De-
loron P, Luty AJ, Day KP, 2006. Association of haptoglobin 
levels with age, parasite density, and haptoglobin genotype in 
a malaria-endemic area of Gabon. Am J Trop Med Hyg 74: 
26–30. 
40. Venables WN, Ripley BD, 2002. Modern Applied Statistics with S. 
New York: Springer-Verlag. 
41. Development R Core Team, 2005. R: A Language and Environ-
ment for Statistical Computing. Vienna, Austria: R Foundation 
for Statistical Computing. 
42. Yenchitsomanus PT, Summers KM, Bhatia KK, Cattani J, Board 
PG, 1985. Extremely high frequencies of alpha-globin gene 
deletion in Madang and on Kar Kar Island, Papua New 
Guinea. Am J Hum Genet 37: 778–784. 
43. Allen SJ, O’Donnell A, Alexander ND, Mgone CS, Peto TE, 
Clegg JB, Alpers MP, Weatherall DJ, 1999. Prevention of ce-
rebral malaria in children in Papua New Guinea by southeast 
Asian ovalocytosis band 3. Am J Trop Med Hyg 60: 1056–1060. 
44. Serjeantson SW, Board PG, Bhatia K, 1992. Population genetics 
in Papua New Guinea: a perspective on human evolution. At-
tenborough R, Alpers MP, eds. Human Biology in Papua New 
Guinea. Oxford, UK: Clarendon Press, 198–233. 
45. Schneweis S, Maier WA, Seitz HM, 1991. Haemolysis of infected 
erythrocytes–a trigger for formation of Plasmodium falci-
parum gametocytes? Parasitol Res 77: 458–460. 
46. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue 
TB, Craig WY, 2000. Reference distributions for the positive 
acute phase serum proteins, alpha1-acid glycoprotein (oroso-
mucoid), alpha1-antitrypsin, and haptoglobin: a practical, 
simple, and clinically relevant approach in a large cohort. J 
Clin Lab Anal 14: 284–292. 
47. Curtain CC, Gajdusek DC, Kidson C, Gorman JG, Champness L, 
Rodrigue R, 1965. Haptoglobins and transferrins in Melanesia: 
relation to hemoglobin, serum haptoglobin and serum iron 
levels in population groups in Papua New Guinea. Am J Phys 
Anthropol 23: 363–379. 
48. Rosales FJ, Topping JD, Smith JE, Shankar AH, Ross AC, 2000. 
Relation of serum retinol to acute phase proteins and malarial 
morbidity in Papua New Guinea children. Am J Clin Nutr 71: 
1582–1588. 
49. Marinkovic S, Baumann H, 1990. Structure, hormonal-regulation, 
and identification of the interleukin-6-responsive and dexa-
methasone-responsive element of the rat haptoglobin gene. 
Mol Cell Biol 10: 1573–1583. 
50. McFaul SJ, Bowman PD, Villa VM, 2000. Hemoglobin stimulates 
the release of proinflammatory cytokines from leukocytes in 
whole blood. J Lab Clin Med 135: 263–269. 
51. Liu X, Spolarics Z, 2003. Methemoglobin is a potent activator of 
endothelial cells by stimulating IL-6 and IL-8 production and 
E-selectin membrane expression. Am J Physiol Cell Physiol 
285: C1036–C1046. 
